Bank of America’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.22M | Buy |
548,090
+15,206
| +3% | +$173K | ﹤0.01% | 3132 |
|
2025
Q1 | $3.54M | Buy |
532,884
+523,793
| +5,762% | +$3.48M | ﹤0.01% | 3504 |
|
2024
Q4 | $100K | Sell |
9,091
-115,557
| -93% | -$1.27M | ﹤0.01% | 5525 |
|
2024
Q3 | $1.53M | Buy |
124,648
+26,850
| +27% | +$330K | ﹤0.01% | 4026 |
|
2024
Q2 | $1.32M | Buy |
97,798
+69,191
| +242% | +$935K | ﹤0.01% | 4023 |
|
2024
Q1 | $386K | Sell |
28,607
-46,732
| -62% | -$631K | ﹤0.01% | 4689 |
|
2023
Q4 | $396K | Buy |
75,339
+17,781
| +31% | +$93.5K | ﹤0.01% | 4772 |
|
2023
Q3 | $227K | Buy |
57,558
+37,211
| +183% | +$147K | ﹤0.01% | 4983 |
|
2023
Q2 | $216K | Sell |
20,347
-5,185
| -20% | -$55.1K | ﹤0.01% | 4957 |
|
2023
Q1 | $213K | Buy |
25,532
+520
| +2% | +$4.33K | ﹤0.01% | 5124 |
|
2022
Q4 | $231K | Buy |
25,012
+19,161
| +327% | +$177K | ﹤0.01% | 5114 |
|
2022
Q3 | $75K | Sell |
5,851
-10,471
| -64% | -$134K | ﹤0.01% | 5657 |
|
2022
Q2 | $215K | Buy |
16,322
+7,690
| +89% | +$101K | ﹤0.01% | 5287 |
|
2022
Q1 | $182K | Sell |
8,632
-45,110
| -84% | -$951K | ﹤0.01% | 5767 |
|
2021
Q4 | $1.29M | Buy |
53,742
+45,345
| +540% | +$1.09M | ﹤0.01% | 4305 |
|
2021
Q3 | $214K | Sell |
8,397
-3,926
| -32% | -$100K | ﹤0.01% | 5424 |
|
2021
Q2 | $415K | Sell |
12,323
-488
| -4% | -$16.4K | ﹤0.01% | 4844 |
|
2021
Q1 | $497K | Buy |
12,811
+9,282
| +263% | +$360K | ﹤0.01% | 4758 |
|
2020
Q4 | $219K | Sell |
3,529
-454
| -11% | -$28.2K | ﹤0.01% | 4831 |
|
2020
Q3 | $134K | Sell |
3,983
-5,173
| -56% | -$174K | ﹤0.01% | 4913 |
|
2020
Q2 | $218K | Buy |
9,156
+3,307
| +57% | +$78.7K | ﹤0.01% | 4648 |
|
2020
Q1 | $134K | Buy |
5,849
+2,236
| +62% | +$51.2K | ﹤0.01% | 4769 |
|
2019
Q4 | $102K | Sell |
3,613
-101
| -3% | -$2.85K | ﹤0.01% | 5176 |
|
2019
Q3 | $79K | Buy |
+3,714
| New | +$79K | ﹤0.01% | 5333 |
|